Solvonis Therapeutics annual gross margin
2022
2023
Solvonis Therapeutics Gross Margin Growth & History (SVNS)
Solvonis Therapeutics's gross margin was 43.95% for fiscal 2023.
View full Solvonis Therapeutics company overviewSolvonis Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 43.95% | −11.40 pp |
| 2022 | 2022-12-31 | 55.35% | — |
Solvonis Therapeutics gross margin trends
Between the periods ended 2022-12-31 and 2023-12-31, Solvonis Therapeutics's gross margin decreased from 55.35% to 43.95%, a change of −11.40 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as reported gross profit divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Solvonis Therapeutics source filings ↗